Connect Biopharma Holdings Limited Postemployment Benefit Expense Defined Benefit Plans
Connect Biopharma Holdings Limited (CNTB) reported Postemployment Benefit Expense Defined Benefit Plans of CNY 971.00 thousand for the 12-month period ending 2020-12-31, per its 20-F filed 2023-04-11.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2023-04-11
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2020-12-31 | 971.00K CNY 20-F · filed 2023-04-11 |
| 2019-12-31 | 1.14M CNY 20-F · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |